Product information

Current status:

Marketed

Current status date:

2005-08-20

Original market date: ^{See footnote 1}

1951-12-31

Product name:

PAPAVERINE HYDROCHLORIDE INJECTION USP

DIN:

00009881 Electronic product monograph is not available

Company:

SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada J4B 1E6

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular ,  Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:12.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

A03AD01 PAPAVERINE

Active ingredient group (AIG) number:^{See footnote5}

0107115001